Artelo Biosciences's total assets for Q2 2025 were $4.36M, an increase of 23.95% from the previous quarter. ARTL total liabilities were $5.76M for the fiscal quarter, a 101.29% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.